Tapentadol, a novel opioid analgesic, represents a important advancement in the treatment of moderate to severe acute pain. Unlike traditional opioids, it exhibits a dual mechanism of action, acting as both a mu-opioid receptor agonist and a noradrenaline reuptake inhibitor. This blend is thought to contribute to a possibly reduced incidence of … Read More